TELO stock icon

Telomir Pharmaceuticals
TELO

$4.16
0.48%

Market Cap: 123M

 

About: Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.

0
Funds holding %
of 6,702 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

33,654,300% more capital invested

Capital invested by funds: $0 [Q4 2023] → $337K (+$337K) [Q1 2024]

700% more funds holding

Funds holding: 0 [Q4 2023] → 7 (+7) [Q1 2024]

700% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 0

0.27% more ownership

Funds ownership: 0% [Q4 2023] → 0.27% (+0.27%) [Q1 2024]

Research analyst outlook

We haven’t received any recent analyst ratings for TELO.

Financial journalist opinion